ArticleDiabetes, obesity & metabolism2021

Patient-reported outcomes in a study of human regular U-500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes.

Jieling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.